Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis

AUTHOR

OTS

DATE

October 31, 2019

CATEGORIES

Post Views: 259

Price NL, Miguel V, Ding W, Singh AK, Malik S, Rotllan N, Moshnikova A, Toczek J, Zeiss C, Sadeghi MM, Arias N, Baldán Á, Andreev OA, Rodríguez-Puyol D, Bahal R, Reshetnyak YK, Suárez Y, Fernández-Hernando C, Lamas S.
JCI Insight. 2019 Oct 15.

PubMed

Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation

Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation
April 23rd, 2021|0 Comments
Hovlinc is a recently evolved class of ribozyme found in human lncRNA

Hovlinc is a recently evolved class of ribozyme found in human lncRNA
April 23rd, 2021|0 Comments
miR-135a-5p mediates memory and synaptic impairments via the Rock2/Adducin1 signaling pathway in a mouse model of Alzheimer’s disease

miR-135a-5p mediates memory and synaptic impairments via the Rock2/Adducin1 signaling pathway in a mouse model of Alzheimer’s disease
April 23rd, 2021|0 Comments
Small extracellular vesicles containing miR-486-5p promote angiogenesis after myocardial infarction in mice and nonhuman primates

Small extracellular vesicles containing miR-486-5p promote angiogenesis after myocardial infarction in mice and nonhuman primates
April 23rd, 2021|0 Comments
Decreased miR-214-3p activates NF-κB pathway and aggravates osteoarthritis progression

Decreased miR-214-3p activates NF-κB pathway and aggravates osteoarthritis progression
April 23rd, 2021|0 Comments
Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs

Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs
March 15th, 2021|0 Comments

Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis

Related articles

Subscribe to our Newsletter

Resources

Stay Connected

Search

Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis

Related articles

Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation

Hovlinc is a recently evolved class of ribozyme found in human lncRNA

miR-135a-5p mediates memory and synaptic impairments via the Rock2/Adducin1 signaling pathway in a mouse model of Alzheimer’s disease

Small extracellular vesicles containing miR-486-5p promote angiogenesis after myocardial infarction in mice and nonhuman primates

Decreased miR-214-3p activates NF-κB pathway and aggravates osteoarthritis progression

Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs

Subscribe to our Newsletter

Resources

Stay Connected

Search

Login to your account

Reset Password

Signup to your Account

Answers

Job Alerts

Account Activation